| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.9 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |